Pages
Products

Human FancD2 Knockdown Cell Line-HeLa

For research use only. Not intended for any clinical use.

Cat. No. :   CSC-RK0026

Host Cell :   HeLa Validation :   Real-Time RCR

Inquire for Price

Cell Line Information

Safety and Packaging

Gene Information

Cat. No. CSC-RK0026
Target Gene FANCD2
Abbr HeLa-HuFancD2 Knockdown
Alias FANCD2, FAD, FA4, FACD, FAD2, FA-D2, FANCD
Host Cell HeLa
Host Cell Species Homo sapiens (Human)
Applications

(1) Studying gene functions

(2) Studying gene interactions and signaling pathways

(3) Target validation and drug discovery

(4) Designing diseases models

Morphology Epithelial
Size >1 × 106 cells / vial
Stability Validated for at least 10 passages
Validation Real-Time RCR
Shipping Dry ice
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations The following safety precautions should be observed.
1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.
2. No eating, drinking or smoking while handling the stable line.
3. Wash hands after handling the stable line and before leaving the lab.
4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.
5. All waste should be considered hazardous.
6. Dispose of all liquid waste after each experiment and treat with bleach.
Ship Dry ice
Gene Name FANCD2 Fanconi anemia, complementation group D2 [ Homo sapiens ]
Gene Symbol FANCD2
Synonyms FA4; FAD; FACD; FAD2; FA-D2; FANCD
Gene Description Fanconi anemia, complementation group D2
GeneID 2177
Uni ProtID Q9BXW9
mRNA Refseq NM_033084.3
Protein Refseq NP_149075.2
Chromosome Location 3p26
Function protein binding;
Pathway BARD1 signaling events, organism-specific biosystem; DNA Repair, organism-specific biosystem; DNA damage response, organism-specific biosystem; Fanconi Anemia pathway, organism-specific biosystem; Fanconi anemia pathway, organism-specific biosystem; Fanconi anemia pathway, conserved biosystem; Regulation of the Fanconi anemia pathway, organism-specific biosystem;
MIM 613984
Quick Inquiry

Background

Q & A

Customer Reviews

The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in two transcript variants encoding different isoforms.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction